Clarus Therapeutics Hldgs Inc (CRXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRXT | ZTS | TAK | UTHR | NBIX |
| Company | Clarus Therapeutics Hldgs Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.0650 | 182.26 | 13.69 | 336.40 | 145.89 |
| High | 0.0749 | 183.85 | 13.79 | 340.44 | 148.02 |
| Low | 0.0475 | 179.26 | 13.69 | 336.32 | 144.35 |
| Last | 0.0475 | 179.84 | 13.77 | 338.22 | 146.80 |
| Change | -0.0215 | -0.92 | +0.10 | +1.85 | +0.70 |
| % Change | -31.16% | -0.51% | +0.73% | +0.55% | +0.48% |
| Volume | 2,737,100 | 2,437,300 | 2,454,800 | 290,200 | 744,700 |
| 20-Day Average Volume | 4,348,840 | 2,007,245 | 2,035,820 | 454,265 | 668,220 |
| Previous Close | 0.0690 | 180.76 | 13.67 | 336.37 | 146.10 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2088 | 177.62 | 13.36 | 325.73 | 143.90 |
| 20-Day Raw Stochastic | 0.00% | 55.76% | 93.26% | 83.51% | 76.74% |
| 20-Day Relative Strength | 26.48% | 56.40% | 60.13% | 71.16% | 60.33% |
| Weighted Alpha | -96.72 | -2.59 | -8.28 | +55.32 | +40.41 |
| Today's Opinion | 100% Sell | 56% Buy | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 56% Buy | 24% Sell | 100% Buy | 100% Buy |
| Last Month's Opinion | 100% Sell | 64% Sell | 100% Sell | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -69.75% since 08/29/22 | +0.71% since 07/19/24 | +3.07% since 07/19/24 | +2.75% since 07/19/24 | +0.76% since 07/19/24 |
| Low | 0.0475 on 09/06/22 | 178.39 on 07/24/24 | 13.40 on 07/22/24 | 325.54 on 07/22/24 | 143.97 on 07/24/24 |
| High | 0.1400 on 08/30/22 | 186.45 on 07/25/24 | 13.83 on 07/25/24 | 343.98 on 07/25/24 | 148.88 on 07/22/24 |
| 1-Month | |||||
| %Chg | -84.34% since 08/05/22 | +5.23% since 06/26/24 | +6.58% since 06/26/24 | +6.04% since 06/26/24 | +8.08% since 06/26/24 |
| Low | 0.0475 on 09/06/22 | 171.51 on 07/10/24 | 12.86 on 06/27/24 | 309.04 on 07/03/24 | 134.03 on 06/27/24 |
| High | 0.3489 on 08/15/22 | 186.45 on 07/25/24 | 13.83 on 07/25/24 | 343.98 on 07/25/24 | 150.39 on 07/16/24 |
| 3-Month | |||||
| %Chg | -90.08% since 06/06/22 | +13.52% since 04/26/24 | +5.68% since 04/26/24 | +44.63% since 04/26/24 | +7.95% since 04/26/24 |
| Low | 0.0475 on 09/06/22 | 158.04 on 05/01/24 | 12.57 on 06/20/24 | 233.31 on 04/30/24 | 129.33 on 06/20/24 |
| High | 0.4659 on 06/07/22 | 186.45 on 07/25/24 | 13.83 on 07/25/24 | 343.98 on 07/25/24 | 150.39 on 07/16/24 |
| 6-Month | |||||
| %Chg | -93.21% since 03/04/22 | -6.10% since 01/26/24 | -5.68% since 01/26/24 | +55.14% since 01/26/24 | +3.27% since 01/26/24 |
| Low | 0.0475 on 09/06/22 | 144.80 on 04/22/24 | 12.57 on 06/20/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 3.9400 on 04/20/22 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 343.98 on 07/25/24 | 150.39 on 07/16/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,471 | 82,060,096 | 43,579,804 | 15,002,084 | 14,773,512 |
| Shares Outstanding, K | 52,021 | 456,295 | 3,164,837 | 44,356 | 100,637 |
| Annual Sales | 13,960,000 | 8,544,000,000 | 29,419,960,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -40,620,000 | 2,344,000,000 | 994,060,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 4,050,000 | 2,190,000,000 | 6,938,670,000 | 677,700,000 | 515,300,000 |
| Last Quarter Net Income | -10,690,000 | 599,000,000 | -46,010,000 | 306,600,000 | 43,400,000 |
| 60-Month Beta | 1.96 | 0.86 | 0.54 | 0.55 | 0.37 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/18/22 | 1.38 on 05/02/24 | 0.00 on 05/09/24 | 6.17 on 05/01/24 | 0.42 on 05/01/24 |
| Latest Earnings Date | 08/22/22 | 08/06/24 | 07/31/24 | 07/31/24 | 08/01/24 |
| Most Recent Dividend | N/A | 0.432 on 07/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 07/18/24 | 03/27/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 33.54 | 8.76 | 15.90 | 40.25 |